Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jan M. Pawlicki
Observed names:
Jan M Pawlicki,
Jan Pawlicki,
Jan M. Pawlicki
Institution:
University of Pennsylvania
Observed institutions:
Children's Hospital of Philadelphia,
Howard Hughes Medical Institute,
Yale University,
Inovio Pharmaceuticals (United States),
University of Pennsylvania
ORCID:
0000-0002-2000-512X
Observed ORCID:
0000-0002-2000-512X
OpenAlex ID:
A5050688181
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
2020
·
Pablo Tebas
, ShuPing Yang
, et al.
·
EClinicalMedicine
·
270
PDF
Tissue-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1
2012
·
Stephan Kadauke
, Maheshi I. Udugama
, et al.
·
Cell
·
233
PDF
Primary microRNA transcript retention at sites of transcription leads to enhanced microRNA production
2008
·
Jan M. Pawlicki
, Joan A. Steitz
·
The Journal of Cell Biology
·
148
PDF
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
2016
·
Asim Saha
, Roddy S. O’Connor
, et al.
·
Journal of Clinical Investigation
·
91
PDF
Nuclear networking fashions pre-messenger RNA and primary microRNA transcripts for function
2009
·
Jan M. Pawlicki
, Joan A. Steitz
·
Trends in Cell Biology
·
77
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
2021
·
Robert H Vonderheide
, Kimberly A Kraynyak
, et al.
·
Journal for ImmunoTherapy of Cancer
·
45
PDF
Subnuclear compartmentalization of transiently expressed polyadenylated pri-microRNAs: Processing at transcription sites or accumulation in SC35 foci
2009
·
Jan M. Pawlicki
, Joan A. Steitz
·
Cell Cycle
·
24
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
2022
·
Jeffrey M. Jacobson
, David Zahrieh
, et al.
·
Cancer Prevention Research
·
17
PDF
Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability
2023
·
Zhenguo Zi
, Shujuan Du
, et al.
·
Blood Advances
·
9
PDF
Tyrosine phosphorylation is critical for ACLY activity in lipid metabolism and cancer
2020
·
Johnvesly Basappa
, Mahmoud A. ElAzzouny
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
PDF
571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster
2021
·
Pablo Tebas
, Joseph Agnes
, et al.
·
Open Forum Infectious Diseases
·
2
PDF
Abstract 7015: Crosstalk between histone and DNA methylation in the development and progression of ALK+ ALCL
2024
·
Cosimo Lobello
, Shengchun Wang
, et al.
·
Cancer Research
Data from NPM–ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation
2023
·
Jan M. Pawlicki
, David L. Cookmeyer
, et al.
Supplementary Data from NPM–ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation
2023
·
Jan M. Pawlicki
, David L. Cookmeyer
, et al.
Supplementary Data from NPM–ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation
2023
·
Jan M. Pawlicki
, David L. Cookmeyer
, et al.
PDF
Data from NPM–ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation
2023
·
Jan M. Pawlicki
, David L. Cookmeyer
, et al.
Lineage-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1
2011
·
Stephan Kadauke
, Jan M Pawlicki
, et al.
·
Blood
Show more works
View as search
Works count:
17
Citation count:
921
H-index:
9
I10-index:
8
Year
Topic
Type